{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:37:22Z","timestamp":1791005842370,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpeds.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T21:45:04Z","timestamp":1438206304000},"page":"851-856.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"167","author":[{"given":"Carlos E.","family":"Prada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent R.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0770-5516","authenticated-orcid":false,"given":"Robert J.","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Saal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Schorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2015.07.001_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/jmg.2010.081760","article-title":"A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations","volume":"48","author":"Sharif","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.jpeds.2015.07.001_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00259-010-1386-4","article-title":"Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1","volume":"37","author":"Moharir","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jpeds.2015.07.001_bib3","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","article-title":"Optic pathway gliomas: a review","volume":"23","author":"Binning","year":"2007","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.jpeds.2015.07.001_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/pbc.20655","article-title":"Optic pathway gliomas","volume":"46","author":"Jahraus","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2015.07.001_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/pbc.22198","article-title":"Natural history and outcome of optic pathway gliomas in children","volume":"53","author":"Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2015.07.001_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.a.20211","article-title":"Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome","volume":"122A","author":"King","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2015.07.001_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2015.07.001_bib8","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpeds.2015.07.001_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M","article-title":"Intracranial gliomas in neurofibromatosis type 1","volume":"89","author":"Listernick","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jpeds.2015.07.001_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2015.07.001_bib11","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.jpeds.2015.07.001_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-010-0159-z","article-title":"Natural history and management of low-grade glioma in NF-1 children","volume":"100","author":"Hernaiz Driever","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jpeds.2015.07.001_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/eye.2010.99","article-title":"Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit","volume":"24","author":"Pilling","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jpeds.2015.07.001_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.07.001_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1","volume":"127A","author":"Blazo","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2015.07.001_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajmg.a.20654","article-title":"Knowledge without truth: screening for complications of neurofibromatosis type 1 in childhood","volume":"127A","author":"Listernick","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2015.07.001_bib17","series-title":"Clinical predictors and risk of optic pathway glioma in neurofibromatosis type-1","author":"Mian","year":"2006"},{"key":"10.1016\/j.jpeds.2015.07.001_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using US death certificates","volume":"68","author":"Rasmussen","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpeds.2015.07.001_bib19","series-title":"Neurofibromatosis: Phenotype, natural history, and pathogenesis","author":"Friedman","year":"1999"},{"key":"10.1016\/j.jpeds.2015.07.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jpeds.2015.07.001_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.24093","article-title":"Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2015.07.001_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nor206","article-title":"Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12","volume":"14","author":"Amlin-Van Schaick","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpeds.2015.07.001_bib23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615007167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615007167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T11:25:49Z","timestamp":1537442749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347615007167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0022347615007167"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.001","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}